There have been 50 recent insider transactions recorded for CymaBay Therapeutics, Inc. (CBAY), including 11 buys and 39 sells. Total insider buying was valued at $1.92M and total insider selling at $21.25M.
Notable insiders with recent activity include Wiggans Thomas G, Emster Kurt Von, Quinlan Paul T. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CBAY
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-03-22 |
Wiggans Thomas G |
Director |
Return of Shares |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Emster Kurt Von |
Director |
Return of Shares |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Quinlan Paul T |
General Counsel |
Return of Shares |
105,625 |
$22.85 |
$2.41M |
- |
| 2024-03-22 |
Dickinson Klara |
Chief Regulatory Officer |
Return of Shares |
78,000 |
$22.85 |
$1.78M |
- |
| 2024-03-22 |
Loewy Caroline M |
Director |
Return of Shares |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Shah Sujal |
Chief Executive Officer |
Return of Shares |
357,500 |
$22.85 |
$8.17M |
- |
| 2024-03-22 |
Mcwherter Charles |
President of R&d |
Return of Shares |
118,625 |
$22.85 |
$2.71M |
- |
| 2024-03-22 |
Lefebvre Eric |
Director |
Return of Shares |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Wills Robert James |
Director |
Return of Shares |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Dorling Janet |
Director |
Return of Shares |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Shantharam Harish |
Chief Financial Officer |
Return of Shares |
74,750 |
$22.85 |
$1.71M |
- |
| 2024-03-13 |
Quinlan Paul T |
General Counsel |
Option Exercise (Sell) |
41,824 |
$7.89 |
$329.99K |
8,872 |
| 2024-03-13 |
Shah Sujal |
Chief Executive Officer |
Option Exercise (Sell) |
14,625 |
$1.06 |
$15.5K |
- |
| 2024-02-12 |
Dorling Janet |
Director |
Informative Sell |
6,000 |
$31.97 |
$191.85K |
- |
| 2024-01-24 |
Wiggans Thomas G |
Director |
RSU Award |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Emster Kurt Von |
Director |
RSU Award |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Quinlan Paul T |
General Counsel |
RSU Award |
28,438 |
- |
- |
28,438 |
| 2024-01-24 |
Dickinson Klara |
Chief Regulatory Officer |
RSU Award |
21,000 |
- |
- |
21,000 |
| 2024-01-24 |
Loewy Caroline M |
Director |
RSU Award |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Shah Sujal |
Chief Executive Officer |
RSU Award |
96,250 |
- |
- |
267,551 |
| 2024-01-24 |
Mcwherter Charles |
President of R&d |
RSU Award |
31,938 |
- |
- |
46,938 |
| 2024-01-24 |
Lefebvre Eric |
Director |
RSU Award |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Wills Robert James |
Director |
RSU Award |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Dorling Janet |
Director |
RSU Award |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Shantharam Harish |
Chief Financial Officer |
RSU Award |
20,125 |
- |
- |
20,125 |
| 2024-01-19 |
Mcwherter Charles |
President of R&d |
Informative Sell |
2,250 |
$23.67 |
$53.26K |
15,000 |
| 2024-01-16 |
Quinlan Paul T |
General Counsel |
Informative Sell |
5,000 |
$23.58 |
$117.9K |
- |
| 2024-01-16 |
Menold Daniel |
Vice President, Finance |
Informative Sell |
10,000 |
$23.58 |
$235.81K |
- |
| 2024-01-10 |
Dorling Janet |
Director |
Informative Sell |
6,000 |
$23.86 |
$143.14K |
- |
| 2023-12-18 |
Mcwherter Charles |
President of R&d |
Option Exercise (Sell) |
6,504 |
$5.00 |
$32.52K |
- |
| 2023-12-15 |
Quinlan Paul T |
General Counsel |
Informative Sell |
5,000 |
$21.98 |
$109.9K |
- |
| 2023-12-15 |
Menold Daniel |
Vice President, Finance |
Informative Sell |
10,000 |
$21.98 |
$219.85K |
- |
| 2023-12-11 |
Shah Sujal |
Chief Executive Officer |
Option Exercise (Sell) |
12,973 |
$5.00 |
$64.87K |
- |
| 2023-12-11 |
Dorling Janet |
Director |
Informative Sell |
6,000 |
$20.07 |
$120.42K |
- |
| 2023-11-17 |
Mcwherter Charles |
President of R&d |
Option Exercise (Sell) |
236 |
$5.00 |
$1.18K |
234 |
| 2023-11-15 |
Quinlan Paul T |
General Counsel |
Informative Sell |
5,000 |
$17.38 |
$86.89K |
- |
| 2023-11-15 |
Menold Daniel |
Vice President, Finance |
Informative Sell |
- |
$17.38 |
- |
- |
| 2023-11-13 |
Shah Sujal |
Chief Executive Officer |
Option Exercise (Sell) |
12,972 |
$5.00 |
$64.86K |
12,973 |
| 2023-11-10 |
Dorling Janet |
Director |
Informative Sell |
7,000 |
$15.24 |
$106.7K |
- |
| 2023-10-18 |
Mcwherter Charles |
President of R&d |
Option Exercise (Sell) |
10,401 |
$5.00 |
$52.01K |
- |
| 2023-10-16 |
Quinlan Paul T |
General Counsel |
Informative Sell |
5,000 |
$13.76 |
$68.8K |
- |
| 2023-10-16 |
Menold Daniel |
Vice President, Finance |
Informative Sell |
- |
$13.76 |
- |
- |
| 2023-10-09 |
Shah Sujal |
Chief Executive Officer |
Option Exercise (Sell) |
12,972 |
$5.00 |
$64.86K |
25,945 |
| 2023-09-29 |
Emster Kurt Von |
Director |
Option Exercise (Sell) |
5,249 |
$5.00 |
$26.25K |
- |
| 2023-09-18 |
Mcwherter Charles |
President of R&d |
Option Exercise (Sell) |
236 |
$5.00 |
$1.18K |
706 |
| 2023-09-15 |
Quinlan Paul T |
General Counsel |
Informative Sell |
24,000 |
$16.87 |
$404.92K |
- |
| 2023-09-15 |
Menold Daniel |
Vice President, Finance |
Option Exercise (Sell) |
15,000 |
$1.72 |
$25.8K |
- |
| 2023-09-13 |
Avoro Capital Advisors Llc |
10 Percent Owner |
Informative Sell |
250 |
$17.00 |
$4.25K |
250 |
| 2023-09-12 |
Avoro Capital Advisors Llc |
10 Percent Owner |
Informative Sell |
300 |
$17.00 |
$5.1K |
300 |
| 2023-08-18 |
Mcwherter Charles |
President of R&d |
Option Exercise (Sell) |
236 |
$5.00 |
$1.18K |
942 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
